Search research articles
Contact Us
Filters
Showing results (431-440 of 441) with videos related to
Page
of 45
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis
D Frappaz, J Michon, C Coze, et al.
Nature Communications
|
December 18, 2025
Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
Madeline S Merlino, Briah Barksdale, Seble G Negatu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial
C Guglielmi, F Gomez, T Philip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
R Ladenstein, T Philip, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group
M C Favrot, P Ambros, F Schilling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 1999
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study
F Pein, J Michon, D Valteau-Couanet, et al.
Experimental Hematology
|
July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution
M Michallet, T Philip, I Philip, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 441) with videos related to
Sort By:
Page
of 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis
D Frappaz, J Michon, C Coze, et al.
Nature Communications
|
December 18, 2025
Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
Madeline S Merlino, Briah Barksdale, Seble G Negatu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial
C Guglielmi, F Gomez, T Philip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
R Ladenstein, T Philip, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group
M C Favrot, P Ambros, F Schilling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 1999
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury
M A Shipp, M D Abeloff, K H Antman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study
F Pein, J Michon, D Valteau-Couanet, et al.
Experimental Hematology
|
July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution
M Michallet, T Philip, I Philip, et al.
Page
of 45